Brief: Entera Bio Announces Publication Of Phase 2 Hypoparathyroidism Study In The Journal Of Bone And Mineral Research
25/02/2021 14:40
Feb 25 (Reuters) - Entera Bio Ltd ENTX.O :
* ENTERA BIO ANNOUNCES PUBLICATION OF PHASE 2
HYPOPARATHYROIDISM
STUDY IN THE JOURNAL OF BONE AND MINERAL RESEARCH
* ENTERA BIO - PHASE 2A STUDY DEMONSTRATED SAFETY AND
TOLERABILITY
OF EB612 ADMINISTERED FOUR TIMES DAILY FOR 16 WEEKS TO PATIENTS
WITH HYPOPT
Source text for Eikon: ID:nGNX2J2Rq0
Further company coverage: ENTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement